Most Likely to Benefit Men with obesity and low testosterone Patients with insulin resistance or prediabetes Men with metabolic syndrome Individuals with borderline or mild testosterone deficiency Less Likely to Benefit Men with primary hypogonadism Patients with pituitary disorders Men with genetic or testicular causes of low testosterone In these cases, testosterone therapy is often necessary
Missing doses or irregular timing creates fluctuating drug concentrations that reduce appetite suppression and metabolic benefits
A patient may complete enrollment and be found ineligible at the provider review stage, at which point the brand states a refund is provided
However, tirzepatide, the active ingredient in Mounjaro, is also sold under the brand name Zepbound, which is FDA approved for weight management in adults with obesity or who are overweight with a weight-related health condition
Titration decisions are always collaborative
This lower concentration means larger injection volumes for the same dose, which can be an advantage for people who want more precise measurements at lower doses
